GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹1,814 Cr | ₹1,642 Cr | ₹1,173 Cr | ₹893 Cr | ₹896 Cr |
What is the latest Total Current Liabilities ratio of GRANULES INDIA ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹1,814 Cr |
Mar2022 | ₹1,642 Cr |
Mar2021 | ₹1,173 Cr |
Mar2020 | ₹893 Cr |
Mar2019 | ₹896 Cr |
How is Total Current Liabilities of GRANULES INDIA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹1,814 Cr | 10.47 | |
Mar2022 | ₹1,642 Cr | 39.94 | |
Mar2021 | ₹1,173 Cr | 31.31 | |
Mar2020 | ₹893 Cr | -0.34 | |
Mar2019 | ₹896 Cr | - |
Compare Total Current Liabilities of peers of GRANULES INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GRANULES INDIA | ₹10,249.9 Cr | 1.2% | -1.6% | 40.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
GRANULES INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GRANULES INDIA | 1.2% |
-1.6% |
40.3% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses